Edition:
United States

Mirati Therapeutics Inc (MRTX.OQ)

MRTX.OQ on NASDAQ Stock Exchange Capital Market

28.70USD
23 Feb 2018
Change (% chg)

$0.35 (+1.23%)
Prev Close
$28.35
Open
$28.60
Day's High
$28.75
Day's Low
$27.20
Volume
74,630
Avg. Vol
113,684
52-wk High
$30.35
52-wk Low
$2.70

Select another date:

Mon, Jan 8 2018

BRIEF-Beigene And Mirati Therapeutics Announce Exclusive License Agreement For Sitravatinib In The Asia Pacific Region

* BEIGENE AND MIRATI THERAPEUTICS ANNOUNCE EXCLUSIVE LICENSE AGREEMENT FOR SITRAVATINIB IN THE ASIA PACIFIC REGION

BRIEF-Mirati announces advancement of opportunities with inhibitor programs

* Mirati Therapeutics announces advancement of first-in-class opportunities with sitravatinib and kras inhibitor programs

BRIEF-Mirati Therapeutics reports Q3 loss per share of $0.65

* Mirati Therapeutics reports third quarter 2017 financial results

BRIEF-Mirati Therapeutics' says drug included in Stand Up To Cancer's clinical trial initiative for NSCLC patients

* Mirati Therapeutics' mocetinostat included in stand up to cancer's cutting-edge clinical trial initiative for NSCLC patients Source text for Eikon: Further company coverage:

BRIEF-Mirati Therapeutics presents positive data from on-going clinical trials of sitravatinib

* Mirati Therapeutics Inc presents positive preliminary data from on-going clinical trials of sitravatinib in non-small cell lung cancer

Select another date: